BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809
2184 results:

  • 1. The
    Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
    Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
    BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors.
    Cheng Y; Dai Y; Tang H; Lu X; Xie J; Xie W; Zhang Q; Liu Y; Lin S; Yao H; Shang H; Yang K; Liu H; Wu X; Zhang J; Zhang X; Xue L; Wu ZB
    Acta Neuropathol Commun; 2024 Apr; 12(1):61. PubMed ID: 38637883
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
    Schachenhofer J; Gruber VE; Fehrer SV; Haider C; Glatter S; Liszewska E; Höftberger R; Aronica E; Rössler K; Jaworski J; Scholl T; Feucht M
    Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12974. PubMed ID: 38562027
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine prostate cancer.
    Wang Y; Wu N; Li J; Liang J; Zhou D; Cao Q; Li X; Jiang N
    Pharmacol Res; 2024 May; 203():107162. PubMed ID: 38554788
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. DNA damage-regulated autophagy modulator 1 prevents glioblastoma cells proliferation by regulating lysosomal function and autophagic flux stability.
    Zhang H; Luan L; Li X; Sun X; Yang K
    Exp Cell Res; 2024 Apr; 437(2):114016. PubMed ID: 38537746
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach.
    Kartal B; Denizler-Ebiri FN; Güven M; Taşpınar F; Canpınar H; Çetin S; Karaduman T; Küççüktürk S; Castresana J; Taşpınar M
    Med Oncol; 2024 Mar; 41(5):97. PubMed ID: 38532150
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.
    Lee YH; Yoon AR; Yun CO; Chung KC
    J Biol Chem; 2024 Apr; 300(4):107206. PubMed ID: 38519031
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
    Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
    World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. NPS-2143 inhibit glioma progression by suppressing autophagy through mediating AKT-mtor pathway.
    Nie JL; Li Q; Yin HT; Yang JH; Li M; Li Q; Fan XH; Zhao QQ; Wen ZP
    J Cell Mol Med; 2024 Apr; 28(7):e18221. PubMed ID: 38509759
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Just a spoonful of metformin helps the medicine go down.
    Tzaridis T; Wechsler-Reya RJ
    J Clin Invest; 2024 Mar; 134(6):. PubMed ID: 38488006
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Neuroprotective Effects of Polysaccharides and Gallic Acid from
    Rangsinth P; Pattarachotanant N; Wang W; Shiu PH; Zheng C; Li R; Tencomnao T; Chuchawankul S; Prasansuklab A; Cheung TM; Li J; Leung GP
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474465
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem cells, and Therapeutic Targets.
    Jhanwar-Uniyal M; Zeller SL; Spirollari E; Das M; Hanft SJ; Gandhi CD
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474373
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression.
    Dalle Carbonare L; Minoia A; Vareschi A; Piritore FC; Zouari S; Gandini A; Meneghel M; Elia R; Lorenzi P; Antoniazzi F; Pessoa J; Zipeto D; Romanelli MG; Guardavaccaro D; Valenti MT
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474372
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Persistent β-Hexachlorocyclohexane Exposure Impacts cellular Metabolism with a Specific Signature in Normal Human Melanocytes.
    Papaccio F; Caputo S; Iorio A; De Simone P; Ottaviani M; Del Brocco A; Frascione P; Bellei B
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474338
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Daurisoline suppress glioma progression by inhibiting autophagy through PI3K/AKT/mtor pathway and increases TMZ sensitivity.
    Yin HT; Hui-Lu ; Yang JH; Li Q; Li M; Zhao QQ; Wen ZP
    Biochem Pharmacol; 2024 May; 223():116113. PubMed ID: 38460907
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Novel MED15::ATF1 fusion in a pediatric melanoma with spitzoid features and aggressive presentation.
    Furtado LV; Cardenas M; Santiago T; Ruiz RE; Shi Z; Pappo A; Kacar M
    Genes Chromosomes Cancer; 2024 Mar; 63(3):e23230. PubMed ID: 38459940
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Effectively α-Terpineol Suppresses Glioblastoma Aggressive Behavior and Downregulates KDELC2 Expression.
    Jin JS; Chou JM; Tsai WC; Chen YC; Chen Y; Ong JR; Tsai YL
    Phytomedicine; 2024 May; 127():155471. PubMed ID: 38452695
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 110.